|
Day 1 | Day 2
Day One |
Chairman’s Opening Remarks And Welcome |
| Session One: The business sense of compliance and measuring your ROI |
Innovating Patient Compliance for the future of your brands
Michael Morgan-Curran, Innovation Group, AstraZeneca |
Case Study: Title TBC
Eugene Osei-Bonsu, Senior Product Manager - Renal Medicine, Shire |
Going back to the fundamentals of patient programmes – insights derived from real life failures and the successes
Chris Venn, European Brand Manager, Pfizer |
The value of innovation in Patient Compliance
Morna Butler, Executive Director Global Operations, Innovex
Jacco Keja, Vice President, Quintiles Consulting |
| Session Two: Understand and Influence Patient Behaviour |
Why patient segmentation is critical for the brand success
Marta Wielondek, Brand Director, Novartis |
How health psychology increases the ROI of an adherence programme
Professor Keith Petrie, Clinical Advisor – Behavioural Psychology, Atlantis Healthcare |
Workshops:
How to use health psychology to improve adherence programmes
Professor Keith Petrie, Clinical Advisor – Behavioural Psychology, Atlantis Healthcare
Josh Taylor, General Manager, Atlantis Healthcare
From disease awareness to patient control: How e-CRM changes everything and allows you to dream about what was not possible a few years ago
Pierre de Nayer, Partner, Citobi
Practical principals that will help you design highly effective patient compliance programmes around the globe and take into account differences in local cultures and laws
Bill Henderson, Group VP –Patient Support Services, International SOS |
Dispelling myths about adherence
Dr. Bernard Vrijens, Chief Scientist, Aardex Group |
A review of GP Familiarity and Attitudes to Medicine Use Reviews
Ian Hunter, Pharmacy Development Manager, Pfizer |
| Session Three: Successful compliance and communication methods |
The need to build a complete programme for patient concordance
Wendy Clyne, Assistant Director: Medicines Partnership Programme, National Prescribing Centre |
The importance of increasing patient compliance to your return on investment
Francisco Sanches Osorio, International Strategic Marketing Manager, Bial – Portela & Companhia SA |
Direct to patient links enhancing compliance – optimised use of a patient hotline
Marc Heim, Sr. Group Leader Marketing, Nycomed |
Cocktail Networking Party |
END OF DAY ONE |
Day 1 | Day 2
Back
To Top
Day Two |
Chairman’s Opening Remarks |
| Session Four: Work with stakeholders to support patients and deliver your information |
A nurse’s perspective on the value of working with pharmaceutical companies to drive patient health
Janet Davies, Executive Director for Service Delivery, Royal College of Nurses |
The role of pharmacists in persistence and patient health
Clare Kerr, Pharmacy Services Manager, Lloyds Pharmacy |
Build great relationships with patient groups for a win-win situation
Keith Allan, Head of Advocacy, Novartis |
| Session Five: Technological innovations to revolutionise compliance and persistence |
Electronic Patient Records, patient registries and active surveillance: Game, set and match for compliance?
Steve Mott, Independent Expert formerly CEO, Medicines.org.uk |
The Mileage still left in SMS and reminders
Manos Papadakis, Brand Manager, GlaxoSmithKline |
Don’t talk to patients/physicians, talk with them (2.0)
Murat Tanoren, Product Manager, Pfizer |
Interactive Roundtables
- Using the Internet to Communicate with Patients
Joanne Shaw, Chairman, Datapharm Communications
- Developing Relations with Pharmacies
Michael Holden, Balance Solutions
- Behavioural change strategy using Software Agent System Design
Carolyn Choh, Professor, St. Josephs University (tbc)
- Patient Compliance from a Brand perspective
Eugene Osei-Bonsu (tbc)
- Working with GP’s to improve the impact of compliance programmes
Ian Hunter, Pharmacy Development Manager, Pfizer
|
END OF DAY CONFERENCE |
Day 1 | Day 2
Back
To Top |
|
 |
|
